Pelletization has attracted much attention across the nutraceutical sector. Experts from ACG explain why.

Nutraceuticals are gaining popularity as an effective tool for maintaining health as public awareness of the advantages of health supplements grows. According to market analysis, the global nutraceutical segment is anticipated to increase in value from $450 billion in 2021 to $746 billion by 2028, with a projected compound annual growth rate (CAGR) of around 8.8%.¹

EPM conducted a roundtable with several pharma experts to learn what industry trends to watch out for in 2023, from AI drug discovery through to the rise of decentralised trials.

The time has come to transition to sustainable strategies – centred around inclusion, innovation, and integration. 2023 will continue to pave the way towards sustainable manufacturing, with a growing number of organisations placing focus on creating long-term solutions.

Healthcare providers have evolved in recent years and broadened their business focus to new areas. An increased spotlight on health and wellness, heightened by COVID, continues to play a large part in the growth of pioneering segments involving nutraceuticals, functional foods and nutricosmetics

According to a recent study by Allied Market Research, the global nutraceuticals market size is projected to reach $650.5 billion by 2030, registering a CAGR of 3.9% from 2021 to 2030.¹

Dahanu-based Zero Liquid Discharge (ZLD) plant nominated for Industrial Project of the Year

ACG, a leading supplier of integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is thrilled to announce its nomination for the Global Water Intelligence’s Industrial Project of the Year Award. Established in 2006 by Global Water Intelligence, the awards recognise the most important achievements in the international water industry.

Dr Subhashis Chakraborty, head of Global Product Management, ACG Capsules

In the wake of the ban on titanium dioxide (TiO₂) E171 in the production of food and dietary supplements in the EU, the pharmaceutical industry may face a similar ban as early as 2025.